Faculty

Institution

Unit

Venue

Ariel Nelson MD

Assistant Professor

Medical College of Wisconsin

Affiliations

Faculty Collaboration Database

Ariel Nelson Md is currently serving as a Faculty Collaboration Database Assistant Professor at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ariel Nelson MD

Medical College of Wisconsin

Assistant Professor

You can click a keyword to filter the displayed items

oncology urology cancer care cancer treatment cancer immunotherapy genitourinary cancers cancer research medicine clinical research immunology immune checkpoint inhibitors bladder cancer pharmacology immunotherapy cancer cells surgical oncology cancer management hematology pharmacotherapy oncogenes molecular cancer medicinal research outcomes research bone marrow transplantation cellular therapy anti-cancer agents advanced urothelial cancer advanced urothelial carcinoma jama oncology clinical transplantation therapeutic efficacy cancer biology treatment options cancer disparities cancer discovery cancer immunosurveillance transplantation medicine combined modality treatment health care disparities disease progression myeloid neoplasia poor performance status clinical outcomes overall response rate second line ici metastatic urothelial carcinoma pediatric pulmonology nuclear medicine health systems palliative medicine immunoediting graft rejection cancer prevention emergency radiology pediatric lung diseases drug trials radiation therapy radiation biology radiation therapy planning clinical effectiveness clinical therapeutics clinical implementation antiviral drugs antiviral therapy translational pharmacology tumor targeting cohort studies performance status poor ps new prognostic model response rate variant urothelial carcinoma neoadjuvant pembrolizumab reproductive toxicity seer database worse outcomes

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase 2 Study of Cabozantinib in Combination With Atezolizumab as Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer, (Hcrn Gu18-343) Abate Study.. Journal of Clinical Oncology (2025)

Deepak KilariAniko SzaboKathryn BylowAriel Ann NelsonPeter LangenstroerScott JohnsonArjun SivaramanKenneth JacobsohnChunkit FungSindhuja G KadambiBrian I. RiniMelissa A ReimersRobert S. AlterAsit KR PaulBrendan John GuercioMatthew I. Milowsky

bladder cancerurologyabate studyoncologyclinical researchmuscle-invasive bladder cancercancer treatmentneoadjuvant treatment

Case Report: Oral Lichenoid Mucositis in a Patient With Metastatic Renal Cell Carcinoma Undergoing Treatment With Pembrolizumab and Axitinib. Frontiers in Oncology (2025)

dermatologyoral pathologysarcomakidney cancercase reportsurgical pathologyoral lichenoid mucositispathology

Homologous Recombination Repair (Hrr) Alterations May Be Passenger Events in Patients With Advanced Prostate Cancer (Pc) With High Tumor Mutational Burden (Htmb). Front Oncol (2025)

carcinogenesisadvanced prostate cancercancer geneticsurologycancer discoverypassenger eventshomologous recombination repaironcologyoncogenesdna repaircancer letterpathologyprostate cancergenome instability

Phase 1B/2 Study of Batiraxcept Alone and in Combination With Cabozantinib With or Without Nivolumab for Advanced Clear Cell Renal Cell Carcinoma. The Oncologist (2025)

immunologyimmune checkpoint inhibitorsurologytherapeutic targetscancer immunotherapygenitourinary cancersphase 1b/2oncologykidney canceroncogenesmedicinal researchcancer cellscancer treatment

Homologous Recombination Repair (Hrr) Alterations May Be Passenger Events in Patients With Advanced Prostate Cancer (Pc) With High Tumor Mutational Burden (Htmb).. Journal of Clinical Oncology (2024)

Vineel BhatlapenumarthiNavonil De SarkarAnannya PatwariEmmanuel S. AntonarakisAriel Ann NelsonDeepak Kilari

advanced prostate cancercancer geneticscancer researchtumor biologyurologypassenger eventshomologous recombination repairclinical researchoncologyprostate cancer

Impact of Cytoreductive Nephrectomy (Cn) and Treatment (Trt) Sequence on Overall Survival (Os) in Metastatic Non-Clear Cell Renal Cell Cancer (Nccrcc).. Journal of Clinical Oncology (2024)

Ariel Ann NelsonAniko SzaboDeepak Kilari

short-term variabilityspecific resistancecell biologyneurologystem cell researchvascular biologykey sitebreast canceroverall survivalcancer researchurologychronic kidney diseasetumor biologycytoreductive nephrectomygliomasbrain tumor researchoncogenesmedicinal researchmulti-scale studiestreatment options

New Phase 1 Surpass Trial Cohort: Early-Line Adp-A2M4Cd8 T-Cell Receptor T-Cell Therapy Plus Pembrolizumab in Urothelial Carcinoma.. Journal of Clinical Oncology (2024)

David H AggenAlejandro GarciaJose M Saro SuarezAmy SauerSebastiano CristianiFrancine Elizabeth BrophySharon StreetsElliot NorryAriel Ann NelsonDeepak KilariBenjamin GarmezyJohn A. CharlsonJon ZugazagoitiaEmiliano CalvoIrene MorenoVictor MorenoChristopher J. HoimesDavid S. HongAndres Cervantes

immunologypharmacologyurologypharmacotherapycancer immunotherapygenitourinary cancersclinical trialsoncologyclinical researchurothelial carcinomacancer treatmentsurpass trial cohortcellular therapydrug trialsimmunotherapy

1889P Phase Ib/II Study of Batiraxcept (Bt, Avb-S6-500, an Axl Pathway Inhibitor) in Combination With Cabozantinib (Cabo) in Patients With Advanced Clear Cell Renal Cell Carcinoma (Ccrcc) Who Failed First-Line (1L) Therapy. Annals of Oncology (2023)

N.J. ShahM.T. CampbellS. MaoM.C. OrnsteinN.B. HaasX. GaoH. HammersH. Keshava-PrasadC.J. HoimesA. HussainS. GeorgeT.S. GourdinA. NelsonH. YanV. EsquibelG. McIntyreR. GellerM.H. VossB.I. RiniK. Beckermann

tumor targetingmedicinecancer caremolecular canceranti-cancer agentsantiviral therapycancer researchtranslational pharmacologyurologytherapeutic targetsenzyme inhibitionpharmacologyantiviral drugspharmacotherapydrug discoveryoncologyclinical researchmedicinal researchaxl pathway inhibitor

Disparities in Medical Oncology Visit Adherence Among African American (Aa) Men With Prostate Cancer (Pca). J Clin Oncol (2023)

public healthhealth equitycancer carecancer disparitiescancer educationafrican americanfamily medicineoncologyprostate cancersupportive carehealth policy

Disparities in Medical Oncology Visit Adherence Among African American (Aa) Men With Prostate Cancer (Pca).. Journal of Clinical Oncology (2023)

Ariel Ann NelsonChristina LadwigKristin RiemersmaKathryn A. BylowDeepak Kilari

cancer careracial discriminationdisparitiesoncologyafrican american studiesprostate cancerhealth care disparitiescancer disparities

1
2
3
4
5
6
7
10 / page

Ariel Nelson MD

Assistant Professor

Medical College of Wisconsin

Affiliations

Faculty Collaboration Database

Ariel Nelson Md is currently serving as a Faculty Collaboration Database Assistant Professor at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ariel Nelson MD

Medical College of Wisconsin

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Phase 2 Study of Cabozantinib in Combination With Atezolizumab as Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer, (Hcrn Gu18-343) Abate Study.. Journal of Clinical Oncology (2025)

bladder cancerurologyabate studyoncologyclinical researchmuscle-invasive bladder cancercancer treatmentneoadjuvant treatment

Case Report: Oral Lichenoid Mucositis in a Patient With Metastatic Renal Cell Carcinoma Undergoing Treatment With Pembrolizumab and Axitinib. Frontiers in Oncology (2025)

dermatologyoral pathologysarcomakidney cancercase reportsurgical pathologyoral lichenoid mucositispathology

Homologous Recombination Repair (Hrr) Alterations May Be Passenger Events in Patients With Advanced Prostate Cancer (Pc) With High Tumor Mutational Burden (Htmb). Front Oncol (2025)

Phase 1B/2 Study of Batiraxcept Alone and in Combination With Cabozantinib With or Without Nivolumab for Advanced Clear Cell Renal Cell Carcinoma. The Oncologist (2025)

immunologyimmune checkpoint inhibitorsurologytherapeutic targetscancer immunotherapygenitourinary cancersphase 1b/2oncologykidney canceroncogenesmedicinal researchcancer cellscancer treatment

Vineel BhatlapenumarthiNavonil De SarkarAnannya PatwariEmmanuel S. AntonarakisAriel Ann NelsonDeepak Kilari

advanced prostate cancercancer geneticscancer researchtumor biologyurologypassenger eventshomologous recombination repairclinical researchoncologyprostate cancer

Impact of Cytoreductive Nephrectomy (Cn) and Treatment (Trt) Sequence on Overall Survival (Os) in Metastatic Non-Clear Cell Renal Cell Cancer (Nccrcc).. Journal of Clinical Oncology (2024)

Ariel Ann NelsonAniko SzaboDeepak Kilari

New Phase 1 Surpass Trial Cohort: Early-Line Adp-A2M4Cd8 T-Cell Receptor T-Cell Therapy Plus Pembrolizumab in Urothelial Carcinoma.. Journal of Clinical Oncology (2024)

Disparities in Medical Oncology Visit Adherence Among African American (Aa) Men With Prostate Cancer (Pca). J Clin Oncol (2023)

public healthhealth equitycancer carecancer disparitiescancer educationafrican americanfamily medicineoncologyprostate cancersupportive carehealth policy

Disparities in Medical Oncology Visit Adherence Among African American (Aa) Men With Prostate Cancer (Pca).. Journal of Clinical Oncology (2023)

Ariel Ann NelsonChristina LadwigKristin RiemersmaKathryn A. BylowDeepak Kilari

cancer careracial discriminationdisparitiesoncologyafrican american studiesprostate cancerhealth care disparitiescancer disparities

1
2
3
4
5
6
7
10 / page

Similar Faculty Members

Lawrence Fong

Institution

University of California, San Francisco

malignant disease

cancer immunotherapy

Davendra Sohal, MD

Institution

University of Cincinnati

radiation oncology

colorectal cancer

Li Zhang

Institution

University of California, San Francisco

cancer letter

pathology

Carolina Schinke

Institution

University of Arkansas for Medical Sciences

cancer letter

pathology

Felix Feng

Institution

University of California, San Francisco

prostate cancer

urology

Balazs Halmos

Institution

Albert Einstein College of Medicine

receptor tyrosine kinase

anti-cancer agent

Zachary Klaassen

Institution

Augusta University

prostatic disease

prostate cancer

Aniko Szabo

Institution

Medical College of Wisconsin

prostate cancer incidence

microarray data analysis

Sandy Srinivas

Institution

Stanford University

oncology

urology

Scott Tagawa

Institution

Weill Cornell Medicine

oncology

urology

Similar Faculty Members

Lawrence Fong

Institution

University of California, San Francisco

malignant disease

cancer immunotherapy

Davendra Sohal, MD

Institution

University of Cincinnati

radiation oncology

colorectal cancer

Li Zhang

Institution

University of California, San Francisco

cancer letter

pathology

Carolina Schinke

Institution

University of Arkansas for Medical Sciences

cancer letter

pathology

Felix Feng

Institution

University of California, San Francisco

prostate cancer

urology

Balazs Halmos

Institution

Albert Einstein College of Medicine

receptor tyrosine kinase

anti-cancer agent

Zachary Klaassen

Institution

Augusta University

prostatic disease

prostate cancer

Aniko Szabo

Institution

Medical College of Wisconsin

prostate cancer incidence

microarray data analysis

Sandy Srinivas

Institution

Stanford University

oncology

urology

Scott Tagawa

Institution

Weill Cornell Medicine

oncology

urology